Benitec Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNTC and other ETFs, options, and stocks.About BNTC
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firms' proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration.
CEOJerel A. Banks
CEOJerel A. Banks
Employees18
Employees18
HeadquartersHayward, California
HeadquartersHayward, California
Founded2019
Founded2019
Employees18
Employees18
BNTC Key Statistics
Market cap23.20M
Market cap23.20M
Price-Earnings ratio-0.82
Price-Earnings ratio-0.82
Dividend yield—
Dividend yield—
Average volume56.06K
Average volume56.06K
High today$10.29
High today$10.29
Low today$8.55
Low today$8.55
Open price$9.12
Open price$9.12
Volume78.36K
Volume78.36K
52 Week high$10.29
52 Week high$10.29
52 Week low$1.86
52 Week low$1.86
BNTC News
Yahoo Finance 3d
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference - Yahoo FinanceBenitec Biopharma Inc. HAYWARD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage,...
